News & Events

• October 26, 2017
  226th ENMC International Workshop: Towards Validated and Qualified Biomarkers for Therapy Development for Duchenne Muscular Dystrophy

  Aartsma-Rus A, Ferlini A, McNally EM, Spitali P, Sweeney HL, Aartsma-Rus AM, Szigyarto CAK, Bello L, Bronson A, Brown K, Buccella F, Chadwick J, Ferlini A, Frank D, Hoffman E, Larkindale J, McClorey G, McNally E, Munschauer R, Muntoni F, Owens J, Schara U, Spitali P, Straub V, Sweeney L, Tinsley J, Versnel J, Vroom E, Welch E. 226th ENMC International Workshop: Towards Validated and Qualified Biomarkers for Therapy Development for Duchenne Muscular Dystrophy. Neuromuscular Disorders. 2017 Oct.

• October 24, 2017
  Accelerating the Clinical Trial Process in Duchenne

• September 23, 2017
  Seeking a Better Landscape for Therapy Development in Neuromuscular Disorders

  Larkindale J, Porter JD. Seeking a Better Landscape for Therapy Development in Neuromuscular Disorders. Issues & Opinions: Improved Data Sharing for NMDs. Muscle & Nerve. 2017 Sep 23.

• May 16, 2017
  

  PPMD blogs about D-RSC Annual Meeting

• January 23, 2017
  Towards Validated and Qualified Biomarkers for Therapy Development for Duchenne Muscular Dystrophy